2019. He joined the Wu lab as a postdoc in Oct 2017. Dr. Wu has received numerous awards, including National Institutes of Health (NIH) Directors New Innovator Award, NIH Roadmap Transformative Award, Presidential Early Career Award for Scientists and Engineers (PECASE) given out by President Obama at the White House, American Heart Association (AHA) Innovative Research Award, AHA Established Investigator Award, AHA Merit Award, AHA Distinguished Scientist Award, and Burroughs Wellcome Foundation Innovation in Regulatory Science Award. I vancara, K Vytas, K Kalcher, A Walcarius, J Wang, Nouvelles citations des articles de cet auteur, Nouveaux articles lis aux travaux de recherche de cet auteur, Michigan State University, UC San Diego, Stanford University, Joan and Irwin Jacobs Chancellor Professor, University of California San Diego, Assistant Professor at North Carolina State University, Profesor de Qumica Analtica-Universidad Nacional de Crdoba, Washington State University; Pacific Northwest National Laboratory, Professor of Analytical Chemistry. Dr. Wu serves on the FDA Cellular, Tissue, and Gene Therapies Advisory Committee and is on the Board of the Keystone Symposia. Principal Investigator Joseph C. Wu, MD, PhD | Director, Stanford Cardiovascular Institute Simon H. Stertzer, MD, Professor of Cardiovascular Medicine & Radiology joewu@stanford.edu | Academic Profile Joseph Wu, MD, PhD If you are interested in a predoctoral or postdoctoral position in the lab, please contact Dr. Joseph Wu. She has multidisciplinary training at the interface of bioengineering, molecular biology, and cardiovascular diseases. Dr. Wu has published >500manuscriptswith H-index of 120 onGoogle scholarand recognition as top 0.1% of highly cited researchers inWeb of Scienceforpast 5 years (2018, 2019, 2020, 2021, 2022). JM Luther, H Zheng, Y Wu, AP Alivisatos. The main goals are to (i) understand cardiovascular disease mechanisms, (ii) accelerate drug discovery, (iii) develop "clinical trial in a dish" concept, and (iv) implement precision medicine for prevention and treatment of cardiovascular patients. I think in cardiology we are still not sure what the long-term cardiovascular effects of COVID-19 will be. She earned her MS degree in Bioengineering at Hacettepe University, Turkey and her PhD in Molecular Biology and Genetics at Bilkent University, Turkey. 6000. Dr. Wu has received numerous awards, including National Institutes of Health (NIH) Directors New Innovator Award, NIH Roadmap Transformative Award, Presidential Early Career Award for Scientists and Engineers (PECASE) given out by President Obama at the White House, American Heart Association (AHA) Innovative Research Award, AHA Established Investigator Award, AHA Merit Award, AHA Distinguished Scientist Award, and Burroughs Wellcome Foundation Innovation in Regulatory Science Award. hbbd```b``1kA$&X"Uc8X.\ k&dO"=jL,`{"3+ ` PE He obtained his PhD in the Department of Molecular & Medical Pharmacology withDr. Sam Sanjiv Gambhir. Google Scholar Digital Library; Zhenqin Wu, Bharath Ramsundar, Evan N Feinberg, Joseph Gomes, Caleb Geniesse, Aneesh S Pappu, Karl Leswing, and Vijay Pande. Obviously, it did not pan out for me! Q: In looking at the research landscape, which recent discoveries bring the biggest promise and hope for novel therapies? Nano letters 9 (4), 1699-1703, 2009. Dr. Wu has published >500manuscriptswith H-index of 120 onGoogle scholarand recognition as top 0.1% of highly cited researchers inWeb of Scienceforpast 5 years (2018, 2019, 2020, 2021, 2022). The system can't perform the operation now. Among his trainees , >45 of them are principal investigators in the US or abroad. 2023 American Heart Association, Inc. All rights reserved. In 2022 she joined the laboratory of Dr. Wu where she will use her skills and knowledge in chemical biology to explore cardiac fibrosis and cardio-oncology. She received her Masters' degree at Universidad de Alcal (Spain) working at Dr. Isabel Liste Noya's lab on The role of p27Kip1 in the pluripotency and differentiation of dopaminergic neurons. More established PIs are already quite aware of what is going on. Circulation 108 (11), 1302-1305, 2003. She earned her Bachelor's degree in Biochemistry at Universidad Complutense de Madrid (Spain). It depends on the exact scenario or setting. During his PhD training, Dr. Paik completed HHMI/VUMC Certificate Program in Molecular Medicine, where he was supervised by his clinical mentor Dr. Douglas Sawyer to interact with congestive heart failure patients and to bridge clinical sciences with basic and translational cardiovascular research. During his PhD training, Dr. Paik completed HHMI/VUMC Certificate Program in Molecular Medicine, where he was supervised by his clinical mentor Dr. Douglas Sawyer to interact with congestive heart failure patients and to bridge clinical sciences with basic and translational cardiovascular research. He is . He is board certified in cardiology. Datasets and other research artifacts are a major topic in the scientific community in the recent years. What they may not be aware of, however, is that the work which made these clinical therapies possible were all based on important basic or translational research performed by many different investigators. That can make a big difference. Advertisement intended for healthcare professionals, Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Department of Internal Medicine, Jagiellonian University, Collegium Medicum. Members - ShapiroLab For his postdoc he will focus on disease mechanisms that can influence severity. The following articles are merged in Scholar. Dr. Wu is a recipient of the National Institutes of Health (NIH) Directors New Innovator Award, NIH Roadmap Transformative Award, Presidential Early Career Award for Scientists and Engineers (PECASE) given out by President Obama at the White House, and the Burroughs Wellcome Foundation Innovation in Regulatory Science Award. His current interest in the development of in vitro models for cardiac disease modelling and high-throughput drug testing. Celles qui sont suivies d'un astrisque (, Sur la base des exigences lies au financement, Electroanalysis: An International Journal Devoted to Fundamental and, Journal of the American Chemical Society 125 (9), 2408-2409, Biosensors and Bioelectronics 21 (10), 1887-1892, Electrochemistry communications 4 (10), 743-746, J Wang, J Lu, SB Hocevar, PAM Farias, B Ogorevc, Nucleic acids research 28 (16), 3011-3016, J Li, B Esteban-Fernndez de vila, W Gao, L Zhang, J Wang. LIBSVM: a library for support vector machines. She is concurrently completing a Masters in Clinical Research studying anomalous aortic origins of coronary arteries with Dr. Blackstone. Simon H. Stertzer, MD, Professor of Cardiovascular Medicine & Radiology For full access to this pdf, sign in to an existing account, or purchase an annual subscription. Wu has published >450 manuscripts with H-index of 110 on Google scholar and . If you don't see a "Get It! Dr. Yildirim is a postdoctoral fellow in Dr. Joseph Wus laboratory at the Stanford Cardiovascular Institute. For permissions, please email: journals.permissions@oup.com. Postdoctoral Fellows Dr. Cao obtained his bachelors degree of biotechnology from Shandong University and masters degree of bioengineering from Chinese Academy of Science. He is listed as top 1% of highly cited researchers by Web of Science for past 4 years (2018, 2019, 2020, 2021). She earned her Bachelor's degree in Biochemistry at Universidad Complutense de Madrid (Spain). Q: Speaking of mentors, is mentorship changing in science over time? Just like the influenza virus which we have become accustomed to. He is co-founder ofGreenstone Biosciences, a startup that uses clinical genomics, iPSCs, and AI/ML to accelerate drug discovery. Systematic review and recommendations on the use of resveratrol, Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines, Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine, Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro, Resveratrol Increases Nitric Oxide Synthase, Induces Accumulation of p53 and p21, Licochalcone-A, a novel flavonoid isolated from licorice root (, Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis, Crystal Structure of Quinone Reductase 2 in Complex with Resveratrol, Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats, Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels, Vascular dysfunction in aging: potential effects of resveratrol, an anti-inflammatory phytoestrogen. Dr. Thomas has authored several first and co-authored publications with leading journals in the field such as Biomaterials, Advanced Materials, Nature Biomedical Engineering, Tissue Engineering, Advanced Healthcare Materials, and has also contributed two book chapters on cell encapsulation for angiogenesis, bone and cartilage repair. In other circumstances, for example, if there are very bad outcomes in heart transplantation or very poor leadership in upper managementthen a drastic change is needed. Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. 2018. Xu Cao is currently a TRISH postdoctoral fellow in Dr. Joseph Wus lab at SCVI. From the Google Scholar homepage, click the three strips/show menu icon on the left side of the page. Pets and Your Health / Healthy Bond for Life, La Iniciativa Nacional de Control de la Hipertensin. Dr. Wu has received numerous awards, including National Institutes of Health (NIH) Directors New Innovator Award, NIH Roadmap Transformative Award, Presidential Early Career Award for Scientists and Engineers (PECASE) given out by President Obama at the White House, American Heart Association (AHA) Innovative Research Award, AHA Established Investigator Award, AHA Merit Award, AHA Distinguished Scientist Award, and Burroughs Wellcome Foundation Innovation in Regulatory Science Award. Dr. Wu has published >500 manuscripts with H-index of 118 on Google scholar and recognition as top 0.1% of highly cited researchers in Web of Science for past 5 years (2018, 2019, 2020, 2021, 2022). Joseph Wu Lab | Joseph Wu Lab | Stanford Medicine As you know, some teams are perennial competitors. Experimental cell research 249 (1), 109-115, JM Wu, ZR Wang, TC Hsieh, JL Bruder, JG Zou, YZ Huang, International journal of molecular medicine 8 (1), 3-17, Z Wang, Y Huang, J Zou, K Cao, Y Xu, JM Wu, International journal of molecular medicine 9 (1), 77-79, Y Fu, T Hsieh, J Guo, J Kunicki, MYWT Lee, Z Darzynkiewicz, JM Wu, Biochemical and biophysical research communications 322 (1), 263-270. PVLDB 6, 10 (2013), 925--936. The following articles are merged in Scholar. Joseph Wang. arXiv preprint arXiv:1904.05734(2019). @ WU" link to get the full text via the Libraries' subscriptions. Then he performed PhD study in Leiden University Medical Center from 2015 to 2020 in Netherlands, where he applied human induced pluripotent stem cells (hiPSCs) to model vascular diseases, under the supervision of Dr. Christine L. Mummery and Dr. Valeria Orlova. J Wu, T Xue, JJ Lim, Y Tian, JB Tenenbaum, A Torralba, WT Freeman .
08001 The Connection Attempt Failed,
Articles J
joseph wu google scholar
